hBD-3, ß-Defensin 3 (hBD3) Derivative, human (CHRG01) - 1 mg
- Cat.Number : AS-64886
- Manufacturer Ref. :
-
Availability :
In stock
Alternative choices
CHRG01 is derived from human b-defensin 3 (hBD3) C-terminal amino acids 54 to 67, with all Cys residues substituted with Ser. This substitution removes all disulfide bond linkages within the sequence. CHRG01, like hBD3, displays electrostatic-dependent antimicrobial properties.
Specifications
Chemistry | |
Sequence one letter code |
|
---|---|
Sequence three letter code |
|
Molecular Formula |
|
Molecular Mass/ Weight |
|
Modification | |
Conjugation |
|
Quantity & Purity | |
Purity |
|
Storage & stability | |
Form |
|
Storage Conditions |
|
Activity | |
Biomarker Target | |
Research Area | |
Sub-category Research Area | |
Usage |
|
Source | |
Source / Species |
|
You may also be interested in the following product(s)
![IMG-EN-AS-60740-01.jpg](/assets/cache/e71450e0-4d46-4a0c-9ddb-a9411ce4b767/500x500/as-60740-img-en-as-60740-01.jpg)
![IMG-EN-AS-60741-01.jpg](/assets/cache/6b34c90f-2351-4d7f-944c-122a4a970d71/500x500/as-60741-img-en-as-60741-01.jpg)
![IMG-EN-AS-60743-01.jpg](/assets/cache/9cb690d5-26fc-4513-854e-26ed06ff4a29/500x500/as-60743-img-en-as-60743-01.jpg)
References
Antimicrobial characterization of human beta-defensin 3 derivatives
Antimicrob Agents Chemother . 2003 Sep 01 ; 47(9) 2804 | DOI : 10.1128/AAC.47.9.2804-2809.2003
- D. Hoover
- et al